Recovery From ICUAW Following Severe Respiratory and Cardiac Failure

ConditionsIntensive Care Unit Syndrome Intensive Care Neuropathy Intensive Care (ICU) Myopathy Acute Respiratory Distress Syndrome Cardiac Failure Respiratory Failure Critical Illness Myopathy

Trial statusRecruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

Age18+

SponsorBarts & The London NHS Trust

About this trial

To observe and identify determinants of recovery from intensive care unit-acquired weakness (ICUAW) following a severe cardiorespiratory failure requiring extra-corporeal membrane oxygenation (ECMO). Additionally, to discover the effects of ICUAW on physical function and health-related quality of life (HRQoL) after critical illness. CLEVERER is a clinical observational pilot study.

Eligibility criteria

Qualifiers

Above the age of 18

Adults with severe cardio-respiratory failure requiring ECMO.

Adults who have had personal and professional consultees agree to enrol them in the trial.

Disqualifiers

Previous Stroke

Neuromuscular disease

Malignancy

Underlying neuromuscular disease

Trial design

Treatments tested in this trial

Not listed

Trial groups

100 Participants

are grouped into 1 trial group

Sponsors and collaborators

Barts & The London NHS Trust

Lead sponsor

Queen Mary University of London

Collaborator

Source ClinicalTrials.gov